The drug Vimpat® (lacosamide) will be extended to include treatment of intractable partial epileptic seizures for children aged four to 15 years, in combination with two or more anti-epileptic medicines. The medicine is designed to assist with brain chemicals that send signals to nerves that affect the possibility of seizure.
There are approximately 14,000 children aged 15 years and under with partial onset seizures and this medicine will help 870 children per year who have trouble in controlling their epilepsy and seizures.
The medication is designed to stop children whom suffer seizures that affect only one part of the brain and they experience inadequate seizure control with currently available anti-epileptic drugs.
The medicine will be available on the PBS from 1st of May 2019.